BPC-157
Body Protection Compound-157
BPC-157 is a pentadecapeptide composed of 15 amino acids derived from body protective compound found in human gastric juice. This synthetic peptide demonstrates remarkable healing and regenerative properties across multiple tissue types including muscle, tendon, ligament, bone, and gastrointestinal tract. While primarily research-stage, BPC-157 has shown consistent protective effects in over 100 preclinical studies, making it one of the most promising healing peptides under investigation.
Complete Dosing Guide
Quick Reference
Administration Method
Subcutaneous injection or oral administration
Step-by-Step Dosing Protocol
Dosing Guidelines
Research protocols typically utilize 10-20 mcg/kg body weight, translating to approximately 250-500 mcg daily for a 70kg adult. Subcutaneous administration ranges from 250-500 mcg once daily, while oral protocols often use 500-1000 mcg daily due to reduced bioavailability. Treatment duration varies from 2-8 weeks depending on injury severity. Some protocols use twice-daily dosing (125-250 mcg BID) for acute injuries requiring rapid healing response.
Most people using BPC-157 for healing take 250-500 micrograms once a day. If you weigh more, you might need a slightly higher dose - think about 3-7 micrograms per kilogram of body weight. You can inject it under the skin (most effective) or take it by mouth (though you need a higher dose). Treatment usually lasts 2-8 weeks depending on what you're trying to heal. Some people take smaller doses twice a day for faster healing.
Mixing & Injection
Subcutaneous injection is the preferred method due to higher bioavailability and systemic distribution. Inject into subcutaneous tissue of abdomen, thigh, or deltoid area using insulin syringes. Rotate injection sites to prevent tissue irritation. Oral administration is possible but requires higher doses due to partial degradation in stomach acid. Some protocols combine both routes: oral for gastrointestinal healing and subcutaneous for systemic effects. Reconstitute with bacteriostatic water and use within recommended timeframe.
Subcutaneous injection is the preferred method due to higher bioavailability and systemic distribution. Inject into subcutaneous tissue of abdomen, thigh, or deltoid area using insulin syringes. Rotate injection sites to prevent tissue irritation. Oral administration is possible but requires higher doses due to partial degradation in stomach acid. Some protocols combine both routes: oral for gastrointestinal healing and subcutaneous for systemic effects. Reconstitute with bacteriostatic water and use within recommended timeframe.
Clinical Administration Guidelines
Injection Protocol
- •Subcutaneous injection 1-2x daily at injury site
- •Inject at or near injury site
- •Consistent timing for optimal healing
- •Can be taken with or without food
Monitoring Schedule
- •Weekly healing progress assessment
- •Injury site examination
- •Range of motion testing
- •Pain and function scoring
Dosage Calculator
Medical Disclaimer
BPC-157 is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Any use should occur only under medical supervision in approved research settings.